Nephros, Inc. ( (NEPH) ) has released its Q3 earnings. Here is a breakdown of the information Nephros, Inc. presented to its investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Nephros, Inc. is a Delaware-based company specializing in high-performance water filtration solutions, primarily serving the medical and commercial sectors with a focus on infection control and dialysis water filtration. Their products are distinguished by FDA 510(k) clearance, ensuring safety and performance in critical environments.
In its latest earnings report, Nephros, Inc. highlighted a significant increase in net revenues, reaching $4.764 million for the third quarter of 2025, compared to $3.518 million in the same period of 2024. This growth was driven by both product and service revenues, reflecting the company’s expanding market presence and product adoption.
Key financial metrics from the report include a gross margin increase to $2.915 million, up from $2.149 million in the previous year, and a net income of $337,000 for the quarter, a notable improvement from $183,000 in Q3 2024. The company also reported a positive cash flow from operations, indicating strong financial health and operational efficiency.
Looking ahead, Nephros management remains focused on sustaining growth through strategic sales initiatives and product development, aiming to maintain profitability and positive cash flow. The company’s commitment to innovation and market expansion positions it well for future success in the water filtration industry.